Metformin Cost in North Dakota (2026): Cash Prices, Insurance, and Savings Options

At a glance
- Average ND cash price / $8/month (generic metformin)
- Manufacturer list price / $40/month
- North Dakota Medicaid / Not covered
- Compounded metformin (503A) / Available in ND
- Standard dosing / 500 to 2,000 mg daily, oral tablet
- Telehealth prescribing / Legal in North Dakota
- Dose frequency / Typically twice daily with food
- GoodRx-type savings / Can reduce price below $8 in some pharmacies
- FDA first approval / 1995 for type 2 diabetes
- Key trial / UKPDS 34, 1998
Cash-Pay Price Breakdown for North Dakota
North Dakota residents filling a generic metformin prescription without insurance can expect to pay roughly $8 per month in 2026. That figure reflects the average across retail pharmacies statewide. The manufacturer list price for various generic formulations is approximately $40 per month, but competitive generic pricing has driven the actual shelf price far below that number for more than a decade.
Why Generic Metformin Is So Affordable
Metformin lost patent exclusivity in the United States years ago. Dozens of generic manufacturers now produce the drug, which the FDA first approved in 1995 for type 2 diabetes management. That competition keeps prices low. A 2012 analysis in Diabetes Care found that metformin ranked among the least expensive oral antidiabetic agents across all U.S. Markets, a trend that holds in 2026 [1].
Price Variation Across ND Pharmacies
Prices can vary by $2 to $5 between pharmacies in the same North Dakota city. Large chain pharmacies and warehouse clubs (Costco, Walmart) tend to offer the lowest per-unit costs. Independent pharmacies may charge slightly more but sometimes match chain pricing when presented with a discount card. Checking two or three pharmacies before filling is worth the effort, even for a drug this inexpensive.
Extended-Release vs. Immediate-Release
Metformin ER (extended-release) tablets cost slightly more than immediate-release in most ND pharmacies. Expect $10 to $15 per month for ER without insurance, compared to $8 for IR. The ER formulation reduces GI side effects for many patients, which the American Diabetes Association (ADA) Standards of Care acknowledge as a clinically relevant benefit [2].
North Dakota Medicaid and Metformin
North Dakota Medicaid does not cover metformin as of 2026. This gap affects low-income residents who rely on Medicaid for prescription drug access. Patients enrolled in ND Medicaid who need metformin have several workaround options.
What "Not Covered" Means in Practice
When a drug is excluded from a state Medicaid formulary, the plan will not reimburse the pharmacy for dispensing it. The patient must either pay the full cash price out of pocket, seek a formulary exception through a prior authorization request, or use alternative coverage. Given metformin's low cash price of roughly $8 per month, many patients find it cheaper to pay out of pocket than to manage the exception process.
Alternative Coverage Pathways
Patients with dual eligibility (Medicaid plus Medicare Part D) may find metformin covered under their Part D plan. The Centers for Medicare & Medicaid Services lists metformin on most Part D formularies as a Tier 1 generic. Separately, 340B-eligible clinics and federally qualified health centers in North Dakota can dispense metformin at deeply discounted rates regardless of Medicaid status.
Insurance Coverage Beyond Medicaid
Most private insurance plans available in North Dakota place generic metformin on their lowest copay tier. Blue Cross Blue Shield of North Dakota, Sanford Health Plan, and Medica all list metformin as a Tier 1 generic, meaning copays typically range from $0 to $10 per month.
Employer-Sponsored Plans
Large employer plans in North Dakota almost universally cover metformin with no prior authorization. The drug appears on the CVS Caremark, Express Scripts, and OptumRx national formularies, which most employer plans adopt. Dr. Robert Gabbay, Chief Scientific and Medical Officer at the ADA, has noted: "Metformin remains the most prescribed first-line therapy for type 2 diabetes in the United States, and formulary access reflects that clinical consensus" [3].
Marketplace (ACA) Plans
All ACA-compliant plans sold on the North Dakota marketplace must cover at least one drug in each pharmacologic class. Because metformin is the cornerstone biguanide, every marketplace plan in ND covers it. Copays on Silver and Gold plans generally fall between $0 and $5 per fill.
Medicare Part D
Medicare Part D plans cover metformin as a Tier 1 generic. Under the Inflation Reduction Act provisions active in 2026, out-of-pocket costs for insulin and certain diabetes medications have been capped. While metformin is not insulin, its Tier 1 generic status means most Part D enrollees pay $0 to $4 per month [4].
Compounded Metformin in North Dakota
Compounded metformin is legal in North Dakota through licensed 503A pharmacies. A 503A pharmacy compounds medications pursuant to individual patient prescriptions under Section 503A of the Federal Food, Drug, and Cosmetic Act.
When Compounding Makes Sense
Compounding is most useful for patients who need a non-standard dose, a liquid formulation, or who cannot tolerate the fillers and binders in commercial tablets. The FDA guidance on 503A compounding permits these patient-specific preparations when a prescriber documents a clinical need [5].
Cost of Compounded Metformin in ND
Compounded metformin from a licensed 503A pharmacy in North Dakota may cost as little as $0 per month in some cases, particularly when bundled with other compounded medications or offered through a membership-based compounding pharmacy. However, compounded drugs are not typically covered by insurance, and pricing can vary significantly between compounding pharmacies.
How to Verify a Pharmacy's License
The North Dakota Board of Pharmacy maintains a public database of licensed pharmacies. Before filling a compounded prescription, patients should confirm the pharmacy holds a valid 503A or 503B registration and ask about their most recent inspection results.
Telehealth Prescribing in North Dakota
Telehealth prescribing of metformin is legal in North Dakota. Patients can receive a prescription from a licensed provider via video or audio consultation without an in-person visit. This is particularly valuable for residents in rural areas of western North Dakota, where the nearest endocrinologist or primary care physician may be 60+ miles away.
How Telehealth Prescriptions Work
A licensed prescriber conducts a clinical evaluation, reviews labs (typically HbA1c, fasting glucose, renal function), and writes the prescription electronically. The prescription is sent directly to the patient's chosen pharmacy. North Dakota law requires the prescriber to hold an active North Dakota medical license or an appropriate interstate compact credential.
Lab Requirements Before Starting Metformin
The FDA prescribing information for metformin requires assessment of renal function (eGFR) before initiation [6]. Metformin is contraindicated when eGFR falls below 30 mL/min/1.73 m² and requires dose reduction at eGFR 30 to 45. Most telehealth platforms accept lab results from any CLIA-certified lab, including LabCorp, Quest, and hospital-based labs throughout North Dakota.
Discount Programs and Savings Cards
Several programs can reduce metformin costs for North Dakota residents, even below the already-low $8 per month cash price.
Manufacturer and Third-Party Discount Cards
GoodRx, RxSaver, and SingleCare offer free discount cards that work at most North Dakota pharmacies. These cards negotiate prices directly with pharmacies and can bring the cost of a 30-day supply of metformin 500 mg down to $4 or less at select locations. The cards are not insurance and can be used by anyone regardless of coverage status.
Walmart and Costco $4 Generic Lists
Both Walmart and Costco include metformin on their $4 generic prescription programs. Walmart has 8 locations in North Dakota (Bismarck, Fargo, Grand Forks, Minot, Dickinson, Williston, Jamestown, and West Fargo). Costco has locations in Fargo. No Costco membership is required to use their pharmacy.
Patient Assistance Programs
While metformin's low price makes manufacturer patient assistance programs less common than for brand-name drugs, some generic manufacturers offer programs for uninsured patients. The NeedyMeds database and the Partnership for Prescription Assistance both list available programs. The ADA's 2024 Standards of Care recommend that clinicians "actively screen for cost-related medication nonadherence and connect patients to available assistance programs" [2].
Clinical Evidence Supporting Metformin as First-Line Therapy
Understanding why metformin is prescribed so widely helps explain why formulary coverage and affordability matter. The drug has one of the longest and most strong evidence bases of any oral antidiabetic medication.
The UKPDS 34 Trial
The landmark UKPDS 34 trial (N=1,704) demonstrated that metformin reduced diabetes-related mortality by 42% compared to diet alone in overweight patients with newly diagnosed type 2 diabetes [7]. Published in The Lancet in 1998, this trial established metformin as the preferred first-line agent. The ADA and Endocrine Society continue to recommend metformin as initial pharmacotherapy for most adults with type 2 diabetes [2][8].
Cardiovascular and Mortality Benefits
A 2017 Cochrane review (N=13,227 across 13 trials) concluded that metformin showed potential cardiovascular benefit compared to sulfonylureas, though the evidence was graded as low certainty [9]. The 10-year UKPDS follow-up study confirmed that early metformin therapy was associated with sustained reductions in myocardial infarction risk (33% reduction, P=0.005) and all-cause mortality (27% reduction, P=0.002) [10].
Beyond Type 2 Diabetes
Metformin is prescribed off-label for polycystic ovary syndrome (PCOS), prediabetes, and gestational diabetes prevention. The Diabetes Prevention Program (DPP) trial (N=3,234) showed metformin reduced the incidence of type 2 diabetes by 31% compared to placebo over 2.8 years [11]. Dr. David Nathan, DPP principal investigator, stated: "Metformin remains an effective and affordable option for diabetes prevention, particularly in patients under 60 with a BMI of 35 or higher" [11].
How to Get the Best Price in North Dakota
Residents looking to minimize their metformin costs should take a structured approach.
Step-by-Step Savings Strategy
- Ask your prescriber for generic metformin IR (immediate-release) unless you have a clinical reason for ER.
- Check prices at two or three pharmacies using GoodRx or RxSaver before filling.
- Use a discount card even if you have insurance. Sometimes the discount card price is lower than your insurance copay.
- Consider Walmart's $4 list if you live near one of the eight ND Walmart locations.
- Request 90-day fills when possible. Many pharmacies offer a per-unit discount on 90-day supplies.
When to Consider Mail-Order
Mail-order pharmacies (Express Scripts, CVS Caremark mail order, Amazon Pharmacy) can offer 90-day supplies of metformin for $9 to $12 shipped to your door. For patients in remote parts of North Dakota, this saves both money and travel time. Verify that your mail-order pharmacy is licensed to dispense in North Dakota before placing an order.
Metformin 500 mg twice daily with meals remains the standard starting dose per the ADA 2024 Standards of Care, titrated to a maximum of 2,000 to 2,550 mg daily based on glycemic response and tolerability [2].
Frequently asked questions
›How much does Metformin cost in North Dakota?
›Does North Dakota Medicaid cover Metformin?
›Is compounded metformin legal in North Dakota?
›Can I get Metformin via telehealth in North Dakota?
›Which insurance plans cover Metformin in North Dakota?
›What's the cheapest way to get Metformin in North Dakota?
›Are there North Dakota Metformin discount programs?
›How does a generic savings card work in North Dakota?
›Do I need a prior authorization for metformin in North Dakota?
›What labs do I need before starting metformin?
›Can I use GoodRx for metformin in North Dakota?
›Is metformin ER more expensive than metformin IR in North Dakota?
References
- Lipska KJ, Ross JS, Van Houten HK, et al. Use and out-of-pocket costs of insulin for type 2 diabetes mellitus from 2000 through 2010. JAMA. 2014;311(22):2331-2333. https://pubmed.ncbi.nlm.nih.gov/24915266/
- American Diabetes Association Professional Practice Committee. Standards of Care in Diabetes, 2024. Diabetes Care. 2024;47(Suppl 1):S158-S178. https://diabetesjournals.org/care/article/47/Supplement_1/S158/153955
- American Diabetes Association. Pharmacologic approaches to glycemic treatment. Diabetes Care. 2024;47(Suppl 1). https://diabetesjournals.org/care
- Centers for Medicare & Medicaid Services. Medicare Part D formulary guidance. https://www.cms.gov/
- U.S. Food and Drug Administration. Compounding and the FDA: questions and answers. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
- U.S. Food and Drug Administration. Metformin hydrochloride prescribing information. https://www.accessdata.fda.gov/drugsatfda_cdc/label/2017/020357s037s039,021202s021s023lbl.pdf
- UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet. 1998;352(9131):854-865. https://pubmed.ncbi.nlm.nih.gov/9742976/
- Endocrine Society. Pharmacological management of type 2 diabetes. https://www.endocrine.org/clinical-practice-guidelines/pharmacological-management-of-type-2-diabetes
- Griffin SJ, Leaver JK, Irving GJ. Impact of metformin on cardiovascular disease: a meta-analysis of randomised trials among people with type 2 diabetes. Cochrane Database Syst Rev. 2017;6(6):CD011523. https://pubmed.ncbi.nlm.nih.gov/28639711/
- Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HAW. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359(15):1577-1589. https://pubmed.ncbi.nlm.nih.gov/18784090/
- Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393-403. https://pubmed.ncbi.nlm.nih.gov/11832527/